Syed Ali Aamir Rizvi Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

Syed Ali Aamir Rizvi is Chief Medical Officer of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 345,911 shares of RCKT, which is worth approximately $1.23 Million. The most recent transaction as insider was on Oct 06, 2025, when has been sold 345,911 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 346K

n/a 3M change

n/a 12M change

Total Value Held $1.23 Million

Syed Ali-aamir Rizvi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 06 2025	BUY Grant, award, or other acquisition	-	345,911 Added 50.0%	345,911 Common Stock

Also insider at

CRBU

Caribou Biosciences, Inc. Healthcare

Chief Medical Officer

PSTX

Poseida Therapeutics, Inc. Healthcare

Chief Medical Officer

SAR